Andrés Felipe Miranda-Arboleda

Andrés Felipe Miranda-Arboleda

Auto-generated profile, based on publicly available information

Andrés Felipe Miranda-Arboleda

Cardiac Arrhythmia Service, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
AMAndrés F. Miranda-Arboleda
Andrés F. Miranda-Arboleda
EZEzequiel J Zaidel
Ezequiel J Zaidel
RMRachel Marcus
Rachel Marcus
Maria Jesús PinazoMaria Jesús Pinazo
Maria Jesús Pinazo
LELuis Echeverria
Luis Echeverria
OPOn Behalf Of The Neglected Tropical Diseases And Other Infectious Diseases Affecting The Heart (Net-Heart) Project
On Behalf Of The Neglected Tropical Diseases And Other Infectious Diseases Affecting The Heart (Net-Heart) Project
Background: Chagas disease (CD) is endemic in Latin America; however, its spread to nontropical areas has raised global interest in this condition. Barriers in access to early diagnosis and treatment of both acute and chronic infection and their complications have led to an increasing disease burden outside of Latin America. Our goal was to identify those barriers and to perform an additional analysis of them based on the Inter American Society of Cardiology (SIAC) and the World Heart Federation (WHF) Chagas Roadmap, at a country level in Argentina, Colombia, Spain, and the United States, which serve as representatives of endemic and nonendemic countries. Methodology and principal findings: This is a nonsystematic review of articles published in indexed journals from 1955 to 2021 and of gray literature (local health organizations guidelines, local policies, blogs, and media). We classified barriers to access care as (i) existing difficulties limiting healthcare access; (ii) lack of awareness about CD and its complications; (iii) poor transmission control (vectorial and nonvectorial); (iv) scarce availability of antitrypanosomal drugs; and (v) cultural beliefs and stigma. Region-specific barriers may limit the implementation of roadmaps and require the application of tailored strategies to improve access to appropriate care. Conclusions: Multiple barriers negatively impact the prognosis of CD. Identification of these roadblocks both nationally and globally is important to guide development of appropriate policies and public health programs to reduce the global burden of this disease.

19 May 2024 in Heart Rhythm
Verified
Journal Article
Closed access
JOJose Osorio
Jose Osorio
AMAndres F. Miranda-Arboleda
Andres F. Miranda-Arboleda
AVAlejandro Velasco
Alejandro Velasco
AVAllyson L. Varley
Allyson L. Varley
ARAnil Rajendra
Anil Rajendra
PZPaul C. Zei
Paul C. Zei

16 May 2024 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
UTUsha B. Tedrow
Usha B. Tedrow
AMAndres F. Miranda-Arboleda
Andres F. Miranda-Arboleda
WSWilliam H. Sauer
William H. Sauer
MDMauricio Duque
Mauricio Duque
BKBruce A. Koplan
Bruce A. Koplan
Jorge E RomeroJorge E Romero
Jorge E Romero

30 June 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
SGSebastian Garcia-Zamora
Sebastian Garcia-Zamora
PIPablo A. Iomini
Pablo A. Iomini
LPLaura Pulido
Laura Pulido
AMAndrés F. Miranda-Arboleda
Andrés F. Miranda-Arboleda
PSPilar Lopez Santi
Pilar Lopez Santi
ABAdrian Marco Baranchuk
Adrian Marco Baranchuk
Objetivos. Explorar la frecuencia e impacto de la violencia contra los trabajadores de salud de Argentina y compararlo con el resto de sus pares de Latinoamérica en el contexto de la pandemia por COVID-19. Materiales y métodos. Estudio de corte transversal a través de una encuesta electrónica al personal médico y no médico de Latinoamérica que desempeño tareas asistenciales desde marzo de 2020. Se utilizó una regresión de Poisson para estimar las Razones de Prevalencia crudas (RP) y ajustadas (RPa) con sus respectivos intervalos de confianza al 95%. Resultados. Un total de 3544 participantes de 19 países respondieron la encuesta; 1992 (56,0%) residían en Argentina. Entre los mismos, el 62,9% padeció al menos un hecho de violencia: 97,7% refirió violencia verbal y 11,8% violencia física. El 41,5% de los agredidos padecieron situaciones de violencia al menos una vez por semana. El personal de salud de Argentina vivenció más frecuentemente violencia que los de otros países (62,9% vs. 54,6%, p<0,001), siendo estos eventos más habituales y estresantes (p<0,05). Además, refirieron más frecuentemente haber considerado cambiar sus tareas asistenciales y/o deseos de abandonar su profesión (p<0,001). En la regresión de Poisson, los participantes deArgentina tuvieron una prevalencia de violencia mayor que los trabajadores de salud de la región (14,6%; p<0,001). Conclusiones. Existió una elevada prevalencia de violencia contra el personal de salud de Argentina durante la pandemia por COVID-19. Estos hechos tuvieron un alto impacto negativo entre quienes los padecieron. Nuestros datos sugieren que, esto podría haber sido más frecuente en Argentina respecto de otras regiones del continente.

16 May 2024 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
Jorge E RomeroJorge E Romero
Jorge E Romero
AMAndres F. Miranda-Arboleda
Andres F. Miranda-Arboleda
CHCarolina Hoyos
Carolina Hoyos
CMCarlos D. Matos
Carlos D. Matos
UBUyanga Batnyam
Uyanga Batnyam
UTUsha B. Tedrow
Usha B. Tedrow

3 November 2023 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
EMEdison Muñoz-Ortiz
Edison Muñoz-Ortiz
AMAndrés Felipe Miranda-Arboleda
Andrés Felipe Miranda-Arboleda
YSYesid Alberto Saavedra-González
Yesid Alberto Saavedra-González
JGJairo Alfonso Gándara-Ricardo
Jairo Alfonso Gándara-Ricardo
JVJesús Arnulfo Velásquez-Penagos
Jesús Arnulfo Velásquez-Penagos
JSJuan Manuel Senior-Sanchez
Juan Manuel Senior-Sanchez
Cardiovascular disease is a common cause of morbidity and mortality in pregnant women. Arrhythmias are common complications during pregnancy; however, the data are limited. Our goal was to characterize the epidemiology, clinical presentation, and impact of cardiac arrhythmias on maternal-fetal outcomes. A prospective cohort study from the Colombian Registry of Pregnancy and Cardiovascular Disease was carried out from 2016 to 2019. All patients with tachyarrhythmia or bradyarrhythmia and a minimum follow-up of six months after delivery were included. The primary outcome was a composite of cardiac events defined as pulmonary edema, symptomatic sustained arrhythmia requiring specific therapy, stroke, cardiac arrest, or maternal death. Secondary outcomes were other cardiac, neonatal, and obstetric events. Arrhythmias were the most common cause of referral to our dedicated cardio-obstetric clinic. A total of 92 patients were included, mean age 27±6 years; 8.7% had previous structural heart disease, and cardiology consultation was delayed in 79.4%. The most common arrhythmias were premature ventricular contractions (33%) and paroxysmal reentrant supraventricular tachycardias (15%); 11 patients (12%) had cardiac implantable electronic devices. Cardiac events occurred in 18.4% of patients, obstetric events occurred in 6.5%, and one caesarean was indicated in the context of symptomatic severe mitral stenosis. Adverse neonatal outcomes were observed in 24.3% of newborns. Arrhythmias were the most common cause of referral to a dedicated cardio-obstetric clinic; most had a benign course. Adverse maternal cardiovascular outcomes were significant and there was a high rate of obstetric and neonatal adverse events, underlining the importance of multidisciplinary care.